Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives

Family Planning Clinical Trial

Official title:

Effect of Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03135288
• Other study ID #: CP-LARC
• Status: Completed
• Phase: N/A
• Start date: July 1, 2017
• Est. completion date: April 15, 2019

Study information

• Verified date: July 2019
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Unintended and closely spaced pregnancies are a major public health problem that affects not only the individuals directly involved but also the society indirectly. It increases the risks of infants with adverse outcomes such as preterm, low birth weight and small for gestational age. Pregnancy occurring within six months of the last delivery holds a 7.5-fold increased risk for induced abortion, a 3.3-fold increase in miscarriage and a 1.6-fold increased risk of stillbirth. But, use of contraceptive methods has been shown to reduce unwanted pregnancy, high fertility and maternal mortality rates.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: April 15, 2019
• Est. primary completion date: March 15, 2019
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Women who deliver a live birth at greater than 28 week's gestation.

• Women desire birth spacing for more than one year

• Women who were holding and /or one of her family hold a cell-phone and accept to receive messages and phone calls to remind her with her contraceptive program

Exclusion Criteria:

• Women who refuse to participate in the study.

• Women aren't able to respond to the questionnaire due to their health status.

• Anticipation of difficulty of subsequent communication with the women

• Women with contraindications of using long acting reversible contraception ( contraindicated if intrauterine device or implant use)

Related Conditions & MeSH terms

• Family Planning

Intervention

Device:
• Cell-phone
a reminder of their postpartum family planning visit 5 weeks after the delivery (one week before the scheduled visit) and a phone call 48 hours before the scheduled visit. They will also receive two follow-up phone calls to answer any questions and to remind them with the follow-up visits after insertion. Woman will be given a referral card to the outpatients' family planning clinic denoting her study group and serial number and with a specific date for postpartum family planning visits.

Locations

Country	Name	City	State
Egypt	Assiut Faculty of Medicine	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Initiation of Long acting reversible contraception method		6 months